Dr. Ken Anderson is the Kraft Family Professor of Medicine at Harvard Medical School, as well as Director of the LeBow Institute for Myeloma Therapeutics and Jerome Lipper Multiple Myeloma Center at Dana-Farber Cancer Institute. Over the last four decades, Dr. Anderson and his world-class research team have spearheaded groundbreaking work that led to the identification and validation of novel drug targets. In turn, they have driven research efforts that translated those targets to therapies that have significantly extended the lives of myeloma patients. As a founding MMRF Board Member, Dr. Anderson’s knowledge, passion, and dedication is part of the fiber of our organization. In his #25Voices video, he shares what the field of #myeloma was like before the MMRF and the extraordinary progress that has been made over the course of his career. Dr. Anderson has been a key stakeholder in driving breakthroughs on behalf of the myeloma community. His partnership with the MMRF continues to play a critical role in transforming patient outcomes. #25Voices #MMRF25

свернуть